Repligen reports no adverse effects in phase 1 clinical study so far dne October 30, 2011 Quinazoline Repligen RG3039 spinal muscular atrophy cure spinal muscular atrophy research +
The Current Status of Spinal Muscular Atrophy Therapeutics dne October 16, 2011 ISIS SMNrx Olesoxime Quinazoline spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research stem cell Trophos +
ISIS SMNrx Improves Lifespan and Motor Function in SMA Mice dne October 09, 2011 ISIS SMNrx spinal muscular atrophy cure spinal muscular atrophy research +